1. World Health Organization. (2018). Noncommunicable diseases country profiles 2018.

2. Bruno, G., Merletti, F., Biggeri, A., Bargero, G., Ferrero, S., Runzo, C., ... & Cavallo-Perin, P. (2004). Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes care, 27(11), 2689-2694.

3. Hess, P. L., Al‐Khalidi, H. R., Friedman, D. J., Mulder, H., Kucharska‐Newton, A., Rosamond, W. R., ... & Post, W. S. (2017). The metabolic syndrome and risk of sudden cardiac death: The atherosclerosis risk in communities study. Journal of the American Heart Association, 6(8), e006103. Smith, Joe, (1999), One of Volvo’s core values. [Online] Available: http://www.volvo. com/environment/index.htm (July 7, 1999)

4. Chaban, O.S., (2018), Kak postroit’ s pacientom partnerskie otnosheniya i obespechit’ priverzhennost’ k lecheniyu? Sovety ehksperta [Online] Available: http://health-ua.com/article/30910- kak-postroit-s-patcientom-partnerskie-otnosheniya-i-obespechit-priverzhenno (8 October 2017)

5. Chukaeva, I. I. (2012). Chto takoe priverzhennost’ k lecheniyu i chto mozhno sdelat’ dlya ee uluchsheniya (na primere arterial’noj gipertonii) [What is adherence to treatment and what can be done to improve it (for example, arterial hypertension)]. Lechebnoe delo, (2).

6. Abduhakimova, N. A., Hatamova, D. T., & Kayumov, U. K. (2009). Chastota i urovni nekotoryh osnovnyh komponentov metabolicheskogo sindroma u bol’nyh podagroj pri saharnom diabete i narushennoj tolerantnosti k glyukoze [Frequency and levels of some main components of metabolic syndrome in patients with gout in diabetes and impaired glucose tolerance]. Vrach-aspirant, (3), 182-186.

7. Kayumov, U. K. (2017). Izuchenie nekotoryh vnutrennih boleznej pri metabolicheskom sindrome i razlichnyh kategoriyah giperglikemii [Study of some internal diseases in metabolic syndrome and various categories of hyperglycemia]. Evrazijskij nauchnyj zhurnal, (2), 405-408.